A Study of the Jovi Patch, Powered by Signal Relief, for the Improvement of General Menstrual Discomfort
Signal Relief · with Holy Redeemer Hospital · NCT07825558
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–50 · Women only
- Healthy volunteers
- Not accepted (a condition is required)
- Study type
- Interventional · Not applicable
- Target enrollment
- 50
- US sites recruiting
- 1
- Study start
- May 8, 2026
- Record last updated
- September 17, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This pilot study is testing whether a thin, flexible, drug-free patch called the Jovi Patch (powered by Signal Relief) can help reduce general menstrual discomfort (pain and related symptoms during periods).
The patch contains no medication, wires, or batteries. It uses special micro-metal particles that are thought to interact with the body's natural electrical signals related to pain. Researchers will compare an active version of the patch to a look-alike sham (inactive) patch.
About 50 pre-menopausal women ages 18-50 who have menstrual discomfort (pain score greater than 4 on a 0-10 scale) will be randomly assigned to one of two groups:
Active patch group (larger group) Sham patch group
Participants will wear their assigned patch during six menstrual cycles (starting the day before their period begins and continuing through the week of flow). After three cycles, women in the sham group will switch to the active patch for the remaining three cycles so researchers can also look at the effects of switching.
The main question is whether more women using the active patch achieve at least a 30% reduction in their pain scores compared with those using the sham patch. The study will also track changes in how much menstrual symptoms interfere with daily life, use of pain medications, and any side effects (such as skin irritation).
Participation lasts through six menstrual cycles. The overall study is expected to take up to 12 months.
Being studied: Jovi Patch; Sham Patch
Conditions: General Menstrual Discomfort
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Pre-menopausal female subjects aged 18 -50 years.
- Currently seeking treatment for general menstrual discomfort
- NPRS scale score > 4 at baseline.
- Able and willing to provide informed consent in English without the assistance of an interpreter.
Exclusion Criteria
- Receiving other investigational agents or on another clinical trial.
- Subject has implantable pain device, pacemaker, defibrillator, or other neuromodulation implantable device.
- Known to be pregnant, or plan to become pregnant in the next 6 months
- Current Jovi/Signal Relief users
Recruiting US locations
Redeemer Health
Meadowbrook, PA 19046
Site contact: Ashley Trymbiski · 4452008090 · atrymbiski@gmail.com
Study contacts (from the official record)
- Ashley Trymbiski · 4452008090 · atrymbiski@gmail.com
Similar studies in Pennsylvania
All women’s health studies in Pennsylvania →- RecruitingHealthy volunteersEarly Phase 1
Endometriosis and Microvascular Dysfunction: Role of Inflammation
Penn State University
- Location
- University Park, PA
- Eligibility basics
- Ages 18–45 · Women only
- RecruitingPhase 2
A Study to Investigate Mibavademab in Adult Women With Functional Hypothalamic Amenorrhea
Regeneron Pharmaceuticals
- Location
- Erie, PA + 9 other US sites
- Eligibility basics
- Ages 18–40 · Women only
- RecruitingPhase 3
Human Menopausal Gonadotropin Research in Infertility Assessing Cumulative Live Birth With Frozen Embryo Transfer.
Granata Bio Corporation
- Location
- Bryn Mawr, PA + 14 other US sites
- Eligibility basics
- Ages 18–42 · Women only
- RecruitingPhase 2
HMBeacon: A Phase 2 Study to Evaluate ALN-6400 in Adult and Adolescent Female Patients With VWD and HMB
Alnylam Pharmaceuticals
- Location
- Pittsburgh, PA + 5 other US sites
- Eligibility basics
- Ages 16–45 · Women only